Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04739319 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression

Study acronym: Project AMD
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. 2 versions Re-verified since Jul 20, 2022, no change to tracked fieldsv2-v3
  2. Study First Submitted
Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss worldwide, and nearly two million Australians have some signs of AMD. This proposed project is a prospective, observational study that seeks to to understand the underlying aetiology of AMD, factors associated with differences between age-related macular degeneration (AMD) phenotypes or severities, or between AMD and healthy individuals. It also seeks to understand the natural history of AMD progression and the factors associated with the rate of progression. In this project, the disease phenotype, genotype and severity and rate of progression will be determined based on non-invasive clinical imaging or functional assessment of the retina, from obtaining biological samples from the participants, or from patient-reported outcomes.
Trial Details
NCT Number NCT04739319
Lead Sponsor Center for Eye Research Australia
Conditions
(from sponsor)		 Age Related Macular Degeneration, Geographic Atrophy, AMD, Age-related Macular Degeneration
Related terms Geographic Atrophy, Macular Degeneration
Enrollment 2,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov